A-Z Index | Map | People Finder

James Harrison School of Pharmacy

R. LEE EVANS, Dean
PAUL JUNGNICKEL, Associate Dean for Academic and Student Affairs
DAVID RIESE, Associate Dean for Research and Graduate Programs
KAREN MARLOWE, Assistant Dean for Mobile Campus
KIMBERLY BRAXTON-LLOYD, Assistant Dean for Health Services

THE AUBURN Doctor of Pharmacy (PharmD) degree program is a four-year course of study that requires the completion of the pre-pharmacy curriculum prior to enrollment. The curriculum is designed to facilitate the development of those abilities necessary for entry-level practitioners in various practice settings. Consistent with accreditation standards and guidelines, the curriculum provides an appropriate balance of course work in the following areas: biomedical sciences (basic and clinical); pharmaceutical sciences; behavioral, social, and administrative pharmacy sciences; pharmacy practice; and pharmacy practice experience. The goal of the curriculum is to prepare students who can provide pharmaceutical care and are life-long learners. To accomplish this, the curriculum involves students in continuous patient care responsibilities starting upon entry into the School. Students also participate as active, self-directed learners in interdisciplinary teaching models.

Admission

Course requirements for admission to the James Harrison School of Pharmacy may be satisfied by completing the Pre-Professional Curriculum in the College of Sciences and Mathematics. Any or all of these requirements may be met by transfer of appropriate credit from other institutions.

Admission is limited and is contingent upon available facilities and faculty. To be considered for admission the applicant must have a satisfactory GPA and satisfactory scores on the Pharmacy College Admissions Test (PCAT). A grade of D in any prerequisite course will not be accepted. Students are matriculated into the James Harrison School of Pharmacy only during fall semester. All pre-pharmacy course work must be completed by the end of the summer term before the professional program begins at the start of fall semester.

Applicants must apply to the James Harrison School of Pharmacy through the Pharmacy College Application Service (PharmCAS) and must also complete the School’s Supplemental Application. The James Harrison School of Pharmacy admits students using a rolling admissions process and student applications are prioritized in the order in which they are received. The final deadline for receipt of all application materials is March 1. Students who are successful in meeting the school’s initial screening criteria are required to come to the campus for a personal interview in order to be further considered for admission.

The James Harrison School of Pharmacy’s Doctor of Pharmacy Program admits students to two campuses: the main Auburn Campus and the Mobile Campus located at the University of South Alabama. Students may express a preference for a specific campus, but assignments are made based on available space. Admitted students are notified of their campus assignment at the time an offer of admission is made.

Prospective students may obtain application materials and information, which further outlines policies and procedures, from the school’s website at www.pharmacy.auburn.edu or by contacting the Office of Academic and Student Affairs, 2316 Walker Building, Auburn, AL 36849-5501. Applications through PharmCAS are submitted online at  http://www.pharmcas.org/ .

Admission Requirements

FallHoursSpringHours
BIOL 1020 Principles of Biology
   & BIOL 1021 Principles of Biology Laboratory
4CHEM 1040 Fundamental Chemistry II3
CHEM 1030 Fundamentals Chemistry I3CHEM 1041 Fundamental Chemistry II Laboratory1
CHEM 1031 Fundamental Chemistry I Laboratory1ENGL 1120 English Composition II3
ENGL 1100 English Composition I3PHIL 1030 Ethics and the Health Sciences3
Literature3Additional Humanities3
MATH 1610 Calculus I4Core Fine Arts3
PHYS 1500 General Physics I4Core History3
Core History3CHEM 2080 Organic Chemistry II3
CHEM 2070 Organic Chemistry I3CHEM 2081 Organic Chemistry II Laboratory1
CHEM 2071 Organic Chemistry I Laboratory1STAT 2510 Statistics for Biological and Health Sciences3
BIOL 2500 Human Anatomy and Physiology I4BIOL 2510 Human Anatomy and Physiology II4
BIOL 3200 General Microbiology4BIOL 3020 Genomic Biology24
BIOL 5600 Mammalian Physiology (Biomedical Physiology)5BCHE 3200 Principles of Biochemistry3
Core Social Science3BIOL 3500 Perspectives in Immunology33
 Core Social Science3
 45 43
Total Hours: 88
1

New admission requirements were effective Fall Semester 2010 and thereafter

2

BIOL 3000 can be substituted for BIOL 3020

3

BIOL 5500 can be substituted for BIOL 3500


Doctor of Pharmacy

P1

FallHoursSpringHours
PYDI 9000/9006 Drugs And Diseases I5PYDI 9100/9106 Drugs And Diseases II5
PYDI 9020 Contemporary Aspects of Pharmacy Practice I2PYDI 9120 Contemporary Aspects of Pharmacy Practice II2
PYDI 9080 Foundations Of Pharmacy1PYDI 9130/9136 Drug Literature Evaluation2
PYDI 9090 Pharmacy Practice Experience I2PYDI 9140/9146 Principles of Pharmacokinetics3
PYDI 9010/9016 Patient Centered Skills2PYDI 9190 Pharmacy Practice Experience II2
 PYDI 9110 Pharmacy Law And Ethics2
 12 16
Total Hours: 28

P2

FallHoursSpringHours
PYDI 9200/9206 Drugs and Diseases III8PYDI 9300/9306 Drugs And Diseases IV8
PYDI 9220 Contemporary Aspects of Pharmacy Practice III2PYDI 9320 Contemporary Aspects of Pharmacy Practice IV2
PYDI 9290 Pharmacy Practice Experience III2PYDI 9390 Pharmacy Practice Experience IV2
PYDI 9210/9216 Pharmacy Practice Development, Management, and Evaluation I3PYDI 9310/9316 Pharmacy Practice Development, Management, and Evaluation II3
PYDI 9230/9236 Drug Products I3PYDI 9330/9336 Drug Products II3
 18 18
Total Hours: 36

P3

FallHoursSpringHours
PYDI 9420 Contemporary Aspects of Pharmacy Practice V2PYDI 9520 Contemporary Aspects of Pharmacy Practice VI2
PYDI 9470 Integrated Pharmacotherapy I6PYDI 9570 Integrated Pharmacotherapy III6
PYDI 9480 Integrated Pharmacotherapy II6PYDI 9580 Integrated Pharmacotherapy IV6
PYDI 9490 Pharmacy Practice Experience V2PYDI 9590 Pharmacy Practice Experience VI2
Professional Electives22Professional Electives22
 18 18
Total Hours: 36

P41

FallHours
PYDI 9610 Community Pharmaceutical Care5
PYDI 9620 Medicine I5
PYDI 9640 Primary/Ambulatory Care I5
PYDI 9650 Primary/Ambulatory Care II5
PYDI 9660 Health System Practice5
PYDI 9670 Practice Elective I5
PYDI 9680 Practice Elective II5
PYDI 9600 Drug Information-Selective or 9630 Medicine II - Selective5
PYDI 9690 Professional Seminar1
PYDI 9700 Advanced Practice Experience Professional Communication0
UNIV 4AA0 University Graduation0
 41
Total Hours: 41
1

P4 Rotations begin in May and are completed the following April.

2

Students must reach 3rd year PYDI standing before completing professional electives.


Academic Performance Standards

The implementation of all guidelines will be in addition to those existing policies and standards of the University.

To remain in good standing, students are required to achieve a James Harrison School of Pharmacy GPA of at least 2.25. GPAs will be calculated only from professional course work, which is defined as core pharmacy courses approved by the faculty and listed in the Doctor of Pharmacy curriculum.

The James Harrison School of Pharmacy students with semester or cumulative GPAs below 2.25, or who receive Ds and Fs in required courses, may be dismissed from the James Harrison School of Pharmacy or required to undergo a remedial plan of study as directed by the Committee on Academic Requirements and Professionalism. The remedial plan of study may require students to retake courses in which they received grades of less than C. Policies concerning academic progression, probation, and dismissal are specified in the James Harrison School of Pharmacy’s Academic Performance Standards. A copy of the Standards may be obtained from the James Harrison School of Pharmacy’s Office of Academic and Student Affairs or from the School’s website.

Students must observe pre-requisites and co-requisites stated in the current Auburn University Bulletin. A pre-requisite statement denoting “_-year PYDI standing” indicates that the student must have passed all courses in the prior year of the curriculum.

Any student in the pharmacy curriculum who is subject to academic suspension and desires to re-enter the James Harrison School of Pharmacy must, in addition to complying with the pertinent university regulations, be approved by the James Harrison School of Pharmacy’s Committee on Admissions.

Notes:

  • Students are required to file an application with the Alabama State Board of Pharmacy for registration as an intern at the time they are enrolled in the James Harrison School of Pharmacy. Information and intern registration forms may be obtained from the Alabama State Board of Pharmacy, 111 Village Street, Hoover, AL 35242, or at www.albop.com. Students must maintain a valid Alabama Internship License as a condition of continued enrollment in the James Harrison School of Pharmacy.
  • Upon entering pharmacy school, and at the beginning of each academic year, students are required to furnish documentation of professional liability insurance, current CPR and First Aid certification, personal medical insurance and up-to-date immunizations.
  • Pharmacy students are required to attend the Professional Seminar Series.
  • The Office of Academic and Student Affairs will provide a list of courses that are approved for professional elective credit. Students may not receive credit for taking professional electives until they reach third professional year standing in the James Harrison School of Pharmacy.
  • Students in the Doctor of Pharmacy program are required to own a laptop computer that meets the school’s specifications. Questions about computer specifications should be directed to the School’s Office of Information Technology. Computer literacy must be demonstrated upon entry to pharmacy school.
  • Students having appropriate qualifications and pre-requisites may be able to take graduate course work while enrolled in the Doctor of Pharmacy program.
  • Students are required to adhere to all of the James Harrison School of Pharmacy’s codes, policies, and professional requirements. The School will take disciplinary action against those students who violate such codes, policies, and professional requirements.
  • Students will be required to periodically take examinations to assess their ability to integrate the knowledge, skills, and attitudes learned to date. Students may be required to complete remedial course work should their performance be unsatisfactory.
  • Consistent with the policies of Auburn University, The James Harrison School of Pharmacy reserves the right to make changes at any time in its academic programs, codes, policies, and professional requirements.
  • Students will be notified of their site assignments for the Advanced Practice Experiences at the earliest feasible time, to enable them to make housing arrangements. Rotation sites are located throughout Alabama, western Georgia, the Mississippi Gulf Coast, and the Florida panhandle. Although students may request specific sites, each site has a limited enrollment and students may be assigned to sites they do not request. Students are responsible for procuring housing, including the assessment of its safety and living conditions (e.g., privacy and single-sex housing). Students are also responsible for housing and other living expenses incurred when assigned to rotation sites away from the Auburn campus.

Clinical Pharmacy Practice Courses

PYPP 5023 PATIENT ASSESSMENT 1 (1) LAB. 3. SU. Performing a basic physical assessment and obtaining a medical and medication history.

PYPP 5323 PATIENT ASSESSMENT 2 (2) LEC. 1. LAB. 3. Advanced physical assessment and interpretation of findings.

PYPP 5643 PRIMARY AND AMBULATORY CARE 1 (3) DSL. 3. Advanced practice experience in providing pharmaceutical care to patients as they initially access the health care system.

PYPP 5653 PRIMARY AND AMBULATORY CARE 2 (3) LEC. 3. Pr. PYPP 5643. Continuation of PYPP 5643.

Interdept Pharmacy Courses

PYDI 4980 INTRODUCTION TO UNDERGRADUATE RESEARCH IN PHARMACY (1-3) IND. SU. Departmental approval. Individual problems course. Students will work under the direction of a faculty member on some problem of mutual interest. Course may be repeated for a maximum of 6 credit hours.

PYDI 9000/9006 DRUGS AND DISEASES I (5) LEC. 5. Integrated study of pathophysiology and chemical, pharmacological, biotechnology, and pharmacokinetic principles to explain the action of drugs. Fall.

PYDI 9010/9016 PATIENT CENTERED SKILLS (2) LEC. 2. Development of methods for developing positive, therapeutic relationships with patients through the application of communications skills (empathy, assertiveness training, effective listening, etc.) and other behavioral interventions. Fall.

PYDI 9020 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE I (2) LAB. 6. This course integrates the skills necessary for the provision of pharmaceutical care. Source material introduces and integrates knowledge and skills focusing on patient assessment and communication. Fall.

PYDI 9080 FOUNDATIONS OF PHARMACY (1) WSP. 1. One week experience orienting first year PYDI students to the context, concepts, tools, and skills necessary for understanding of, and success in pharmacy education. Fall.

PYDI 9090 PHARMACY PRACTICE EXPERIENCE I (2) PRA. 2. SU. First of a six-course sequence of introductory practice experience in which the concept of pharmaceutical care is introduced by the provision of basic care to community based patients. Fall.

PYDI 9100/9106 DRUGS AND DISEASES II (5) LEC. 5. Pr. PYDI 9000 or PYDI 9006 or PYDI 5000 or PYDI 5000. Presents, in an integrated manner, pathophysiology and chemical, pharmacological and biotechnology principles to explain the action of drugs; continuation of PYDI 9000/PYDI9006. Spring.

PYDI 9110/9116 PHARMACY LAW AND ETHICS (2) LEC. 2. Basic legal and ethical principles of pharmaceutical care and their effect on the patient drug use process. Spring.

PYDI 9120 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE II (2) LAB. 6. Pr. PYDI 9020 or PYDI 5020. This course integrates pharmaceutical care skills. Source material introduces and integrates knowledge and skills focusing on pharmaceutical calculations, communication, physical assessment and use of clinical literature. Spring.

PYDI 9130/9136 DRUG LITERATURE EVALUATION (2) LEC. 2. Development of the ability to effectively and efficiently retrieve drug information and critically evaluate and interpret studies published in the medical and pharmaceutical literature. Spring.

PYDI 9140/9146 PRINCIPLES OF PHARMACOKINETICS (3) LEC. 3. Pr. PYDI 9000 or PYDI 9006 or PYDI 5000. To prepare students to use pharmacokinetic information and measurements to evaluate drug therapy and recommend appropriate dosing strategies for drug administration and monitoring. Spring.

PYDI 9190 PHARMACY PRACTICE EXPERIENCE II (2) PRA. 2. SU. Pr. PYDI 9090 or PYDI 5090. Second of a six-course sequence of introductory practice experience in which the concept of pharmaceutical care is introduced by the provision of basic care to community-based patients. Spring.

PYDI 9200/9206 DRUGS AND DISEASES III (8) LEC. 8. Pr. (PYDI 9100 or PYDI 9106 or PYDI 5100) and (PYDI 9140 or PYDI 9146 or PYDI 5140). Presentation in an integrated manner of and pathophysiology chemical, pharmacological, biotechnology, and pharmacokinetic principles to explain the action of drugs. Continuation of PYDI 9100/PYDI 9106. Fall.

PYDI 9210/9216 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION I (3) LEC. 3. Overview of the development, management, and evaluation of systems that support the provision of pharmaceutical care for patients in multiple health systems. Fall.

PYDI 9220 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE III (2) LAB. 6. Pr. PYDI 9120 or PYDI 5120. Integrates the provision of pharmaceutical care and pharmacy-specific skills related to drug-related problems. Supportive skills for the pharmaceutical sciences and other integrated skills are a major emphasis. Fall.

PYDI 9230/9236 DRUG PRODUCTS I (3) LEC. 3. Pr. (PYDI 9100 or PYDI 5100 or PYDI 9106 or PYDI 5106) and (PYDI 9120 or PYDI 5120). Physical-chemical and biopharmaceutical principles and technologies used in the preparation of pharmaceutical dosage forms and novel drug delivery systems. Fall.

PYDI 9290 PHARMACY PRACTICE EXPERIENCE III (2) PRA. 2. SU. Pr. PYDI 9190 or PYDI 5190. Third in six-course sequence of introductory practice experience in which pharmaceutical care is provided to moderately complex community based patients.

PYDI 9300/9306 DRUGS AND DISEASES IV (8) LEC. 8. Pr. PYDI 9200 or PYDI 9206 or PYDI 5200. Presentation, in an integrated manner, of pathophysiology and chemical, pharmacological, biotechnology, and pharmacokinetic principles to explain the action of drugs. Continuation of PYDI 9200/PYDI 9206. Spring.

PYDI 9310/9316 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION II (3) LEC. 3. Pr. PYDI 9210 or PYDI 9216 or PYPC 5210. An overview of the development, management, and evaluation of systems that support the provision of pharmaceutical care for patients in multiple health systems. Continuation of PYDI 9210/PYDI 9216. Spring.

PYDI 9320 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE IV (2) LAB. 6. Pr. PYDI 9220 or PYDI 5220. Continuation of PYDI 9220. Spring.

PYDI 9330/9336 DRUG PRODUCTS II (3) LEC. 3. Pr. (PYDI 9230 or PYDI 9236 or PYPS 5230) and PYDI 9200 or PYDI 5200 or PYDI 9206 and PYDI 9220 or PYDI 5220. Physical-chemical and biopharmaceutical principles and technologies used in the preparation of pharmaceutical dosage forms and novel drug delivery systems. Continuation of PYDI 9230/PYDI 9236. Spring.

PYDI 9390 PHARMACY PRACTICE EXPERIENCE IV (2) PRA. 2. SU. Pr. PYDI 9290. Fourth in a six-course sequence of introductory practice experience in which pharmaceutical care is provided to moderately complex community based patients. Spring.

PYDI 9420 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE V (2) LAB. 6. Continuation of PYDI 9320 Fall.

PYDI 9470 INTEGRATED PHARMACOTHERAPY I (6) RCT. 6. Application of the basic, clinical, and socio-behavioral sciences to identifying, preventing and solving health and drug related problems. Fall.

PYDI 9480 INTEGRATED PHARMACOTHERAPY II (6) RCT. 6. Continuation of PYDI 9470. Fall.

PYDI 9490 PHARMACY PRACTICE EXPERIENCE V (2) PRA. 2. SU. Fifth in a six-course sequence of introductory practice experiences in which pharmaceutical care is provided to increasingly complex community based patients along with patient care team management responsibilities. Fall.

PYDI 9510 GERIATRIC CARE (2) LEC. 25. P3 standing in the Harrison School of Pharmacy and eligible to take an elective in the HSOP curriculum. This courses focuses on environmental, psychological, and physiological characteristics that are unique to, or more prevalent among, geriatric patients. Students will be required to evaluate how pharmacists can impact care through interprofessional teams while optimizing the patient's quality of life.

PYDI 9520 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE VI (2) LAB. 6. Pr. PYDI 9420 or PYDI 5420. Continuation of PYDI 9420.

PYDI 9570 INTEGRATED PHARMACOTHERAPY III (6) RCT. 6. Pr. PYDI 5480 or PYDI 9480. Continuation of PYDI 9480. Spring.

PYDI 9580 INTEGRATED PHARMACOTHERAPY IV (6) RCT. 6. Pr. PYDI 5480 or PYDI 9480. Continuation of PYDI 9570. Spring

PYDI 9590 PHARMACY PRACTICE EXPERIENCE VI (2) PRA. 2. SU. Pr. PYDI 9490 or PYDI 5490. Sixth in a six-course sequence of introductory practice experiences in which pharmaceutical care is provided to increasingly complex community based patients along with patient care team management responsibilities. Spring.

PYDI 9600 DRUG INFORMATION-SELECTIVE (5) PRA. 5. Advanced practice experience in providing drug information services to health care providers. Fall, Spring, Summer.

PYDI 9610 COMMUNITY PHARMACEUTICAL CARE (5) PRA. 5. Advanced Practice Experience in a community pharmacy practice setting that provides pharmaceutical care services such as disease management and other advanced patient care activities. Fall, Spring, Summer.

PYDI 9620 MEDICINE I (5) PRA. 5. Advanced practice experience in providing Inpatient Pharmaceutical Care. Fall, Spring, Summer.

PYDI 9630 MEDICINE II - SELECTIVE (5) PRA. 5. Advanced practice experience in providing Inpatient Pharmaceutical Care. Additional experience beyond PYDI 9620. Fall, Spring, Summer.

PYDI 9640 PRIMARY/AMBULATORY CARE I (5) PRA. 5. Advanced practice experience in providing care to patients as they initially access the health care system. Fall, Spring, Summer.

PYDI 9650 PRIMARY/AMBULATORY CARE II (5) PRA. 5. Advanced practice experience in providing pharmaceutical Care to patients as they initially access the health care system. Continuation of PYDI 9640. Fall, Spring, Summer.

PYDI 9660 HEALTH SYSTEM PRACTICE (5) PRA. 5. Advanced practice experience in a health system setting that prepares the student to adapt and function within systems of integrated pharmaceutical care services. Fall, Spring, Summer.

PYDI 9670 PRACTICE ELECTIVE I (5) PRA. 5. Elective experience in an advanced practice experience setting in which the student establishes personal learning goals and responsibilities. Fall, Spring, Summer.

PYDI 9680 PRACTICE ELECTIVE II (5) PRA. 5. Elective experience in an advanced practice experience setting in which the student establishes personal learning goals and responsibilities. Fall, Spring, Summer.

PYDI 9690 PROFESSIONAL SEMINAR (1) PRA. 2. SU. Student will demonstrate the ability to evaluate and synthesize pertinent literature, and effectively communicate pharmacotherapy-related material in one platform (seminar) presentation. Spring.

PYDI 9700 ADVANCED PRACTICE EXPERIENCE PROFESSIONAL COMMUNICATION (0) PRA. SU. Students will synthesize pertinent literature, and communicate pharmacotherapy-related material in patient, journal club, in-service, and written presentations. Spring.

PYDI 9710/9716 METABOLIC SYNDROME (2) LEC. 2. Advanced material on the assessment and treatment of disease states related to Metabolic Syndrome. Spring.

PYDI 9720/9726 MOTIVATIONAL INTERVIEWING (2) LEC. 2. Pr. PYDI 9010 or PYDI 9016 or PYPC 5010 or PYPC 5016. Basic and advanced training and exploration of motivational interviewing. Fall

PYDI 9730/9736 DRUGS IN PREGNANCY (2) LEC. 2. Medication issues related to pregnancy and lactation. Fall.

PYDI 9740/9746 PEDIATRIC PHARMACOTHERAPY (2) LEC. 2. Medication issues related to the pediatric population. Fall.

PYDI 9750/9756 ANTITHROMBOTIC/THROMBOLYTIC THERAPY (2) LEC. 2. Provides the student with a working knowledge of both basic and advanced pharmacotherapeutics issues related to antithrombotic and thrombolytic therapy. Spring.

PYDI 9770/9776 WOMEN'S HEALTH ISSUES (2) LEC. 2. Understanding factors that affect women's premature morbidity and mortality.

PYDI 9780/9786 ACUTE CARE PHARMACOTHERAPY (2) LEC. 2. This course is designed to orient the pharmacy student to the acute care environment and familiarize them with patient disease states and pharmacotherapy associated with the acutely ill patient. Spring.

PYDI 9790/9796 PSYCHIATRIC PHARMACOTHERAPY (2) LEC. 2. To expose pharmacy students to psychiatry and to develop a working knowledge of both basic and advanced pharmacotherapeutic issues related to psychopharmacology. Spring.

PYDI 9800 SURVEY OF MULTI-MODALITY MOLECULAR IMAGING FOR PHARM.D. (2) LEC. 2. State-of-the-art survey of molecular imaging techniques and clinical imaging modalities that are available and their use to monitor the progression of various human diseases.

PYDI 9810/9816 EVIDENCE-BASED PHARMACOTHERAPY (2) LEC. 2. Student pharmacists will become more proficient at literature evaluation and application of evidence-based pharmacotherapy/medicine to patient care. Spring.

PYDI 9960/9966 SPECIAL PROBLEMS IN PHARMACY (1-3) IND. Independent study of problems related to pharmacy under the direction of a faculty member. Departmental approval. Fall. Spring. Course may be repeated for a maximum of 6 credit hours.

PYDI 9970/9976 SPECIAL TOPICS IN PHARMACY (2) LEC. 2. Instruction and discussion in a selected current topic in Pharmacy. Fall, Spring. Course may be repeated for a maximum of 4 credit hours.

Pharmacal Sciences Courses

PYPS 5800 SURVEY OF MULTI-MODALITY MOLECULAR IMAGING (2) LEC. 2. Departmental approval. State-of-the-art survey of molecular imaging techniques that are available and their use to monitor the progression of various human diseases.

PYPS 6800 SURVEY OF MULTI-MODALITY MOLECULAR IMAGING (2) LEC. 2. Departmental approval. State-of-the-art survey of molecular imaging techniques that are available and their use to monitor the progression of various human diseases.

PYPS 7000 INTRODUCTION TO GRANT WRITING (2) LEC. 2. Departmental approval. Course will train students to prepare NIH RO1 grant applications. Students will perpare mock applications on topics of their choosing.

PYPS 7010 PHARMACOKINETICS (4) LEC. 4. Departmental approval. Pharmacokinetic and pharmacodynamic principles and methods used to study the absorption, distribution, metabolism and excretion of drugs.

PYPS 7020 SCIENCE AND TECHNOLOGY OF TABLETING (2) LEC. 2. Pr. PYPS 7030 or departmental approval. Formulation, compression, coating and evaluation of tablets.

PYPS 7021 SCIENCE AND TECHNOLOGY OF TABLETING (2) LAB. 6. Pr. PYPS 7020. Actual formulation, compression, coating and evaluation of tablets.

PYPS 7030 DRUG PRODUCTS AND BIOPHARMACEUTICS (4) LEC. 4. Departmental approval. Formulation, evaluation, and use of various pharmaceutical dosage forms including biopharmaceutical aspects.

PYPS 7040 PHYSICAL PHARMACY (4) LEC. 4. Departmental approval. Application of physical chemical principles to dosage form design and evaluation.

PYPS 7050 NOVEL DOSAGE FORMS (3) LEC. 3. Pr. PYPS 7030 or departmental approval. Theoretical basis and design of controlled release and site specific drug delivery systems.

PYPS 7060 FORMULATION AND DELIVERY OF PEPTIDE/PROTEIN DRUGS (3) LEC. 3. Pr. PYPS 7030 or departmental approval. Formulation and delivery problems unique to peptide/protein pharmaceuticals and strategies to overcome such problems.

PYPS 7070 TRANSPORT PHENOMENA IN PHARMACEUTICAL SYSTEMS (3) LEC. 3. Departmental approval. Mechanisms of drug transport in various pharmaceutical dosage forms and biological systems. Elucidation of methods to characterize drug transport phenomena. Correlation of transport phenomena with drug disposition in the body. Emphasis on peptide, protein, and oligonucleotide drugs.

PYPS 7080 ADVANCED BIOPHARMACEUTICS (3) LEC. 3. Pr. PYPS 7010. The mathematical and pharmacokinetic relationships between physical and chemical properties of a drug and its dosage form and biological effects.

PYPS 7110 STABILITY KINETICS OF PHARMACEUTICALS (3) LEC. 3. Pr. PYPS 7030 or departmental approval. Principles of chemical kinetics as applied to the unique stability problems of the various pharmaceutical dosage forms.

PYPS 7230 ADVANCED MEDICINAL CHEMISTRY I (3) LEC. 3. Departmental approval. Explanation of the principles of Medicinal Chemistry progressing to qualitative and quantitative descriptions of the synthesis, influence of physical and chemical properties of chemical substances on biological activity and biodisposition.

PYPS 7240 ADVANCED MEDICINAL CHEMISTRY II (3) LEC. 3. Pr. PYPS 7230. Departmental approval. Advanced study of organic medicinal agents featuring organic synthesis, chemical and pharmacological properties and current literature topics.

PYPS 7250 DRUG ACTION AND DESIGN (3) LEC. 3. Pr. PYPS 7230 and PYPS 7240. Modern molecular modeling methods with emphasis on computer-aided drug design, quantitative structure activity relationships and combinatorial chemistry.

PYPS 7260 SEPARATION SCIENCE (4) LEC. 4. Departmental approval. A survey of modern separation science with emphasis on analytical scale techniques including as chromatography, liquid chromatography and electrokinetic separations.

PYPS 7270 MASS SPECTROMETRY OF ORGANIC COMPOUNDS (4) LEC. 4. Departmental approval. A survey of modern techniques in as spectrometry with emphasis on fragmentation chemistry and structure education.

PYPS 7290 NEUROPHARMACOLOGY OF DRUG ABUSE (2) LEC. 2. Departmental approval. An in-depth study of drugs of abuse, including mechanisms of action, pharmacokinetics, addiction, physical dependence and the effects of drug use during pregnancy. Substance abuse treatment strategies will also be discussed.

PYPS 7300 NEUROPHARMACOLOGY (3) LEC. 3. Pr. PYPS 6310. Neurochemical mechanisms related to the pharmacological actions of medicinal agents affecting the central nervous system.

PYPS 7310 PSYCHOPHARMACOLOGY 1 (3) LEC. 3. Discussions on anxiety, depression and related disorders.

PYPS 7320 PSYCHOPHARMACOLOGY II (3) LEC. 3. Discussions on schizophrenia, Alzheimer's disease, experimental methods and animal models of disorders.

PYPS 7330 PHARMACOLOGY RESEARCH METHODS (3) LEC. 1. LAB. 9. Experimental design, research methods and data analysis in pharmacology.

PYPS 7340 ORGAN SYSTEMS PHARMACOLOGY I (3) LEC. 3. The course will evaluate the basic principles and rationale for current and novel pharmacological therapeutics for various disease states.

PYPS 7350 ORGAN SYSTEMS PHARMACOLOGY II (3) LEC. 3. The course will evaluate the mechanism of action and rationale for current and novel pharmacological therapeutics for various disease states.

PYPS 7360 CELLULAR & MOLECULAR PHARMACOLOGY & TOXICOLOGY I (3) LEC. 3. Cellular biology course integrated with pharmaceutical sciences for the study of pharmacologically related mechanisms at the molecular and cellular levels.

PYPS 7370 CELLULAR & MOLECULAR PHARMACOLOGY & TOXICOLOGY II (3) LEC. 3. Pr. PYPS 7360. Cellular biology course integrated with pharmaceutical sciences for the study of pharmacologically related mechanisms at the molecular and cellular levels. This is a continuation of PYPS 7360.

PYPS 7500 METABOLISM AND DISPOSITION XENOBIOTICS (2) LEC. 2. Portals of entry, absorption, distribution and elimination of drugs and xenobiotics. Metabolic mechanisms relevant to chemical structure and principles of pharmacokinetics will be emphasized.

PYPS 7510 ENVIRONMENTAL TOXICOLOGY (3) LEC. 3. Mechanisms of action of agricultural and industrial chemicals, drugs, radiation, metals, gases, air particulates, food additives, plant and food poisons in the environment.

PYPS 7600 HETEROCYCLIC MEDICINAL CHEMISTRY (3) LEC. 3. Pr. CHEM 7220. Departmental approval. A survey of chemical nature of heterocyclic moieties of medicinal substances with emphasis on methods of synthesis of medicinally important compounds containing a heterocyclic ring.

PYPS 7930 DIRECTED STUDIES IN PHARMACAL SCIENCES (1-3) LEC. Departmental approval. Selected laboratory research topics in the pharmaceutical sciences. Course may be repeated for a maximum of 6 credit hours.

PYPS 7950 SEMINAR (1) SEM. 1. SU. 1 CR; may be repeated multiple times for credit. Course may be repeated for a maximum of 6 credit hours.

PYPS 7960 SPECIAL PROBLEMS IN PHARMACAL SCIENCES (1-3) IND. Pr. At least 6 credits each with a minimum grade of B in PYPS 7000-7999 Selected study topics in the pharmaceutical sciences. Departmental approval and 6 hours of 7000-level courses. Course may be repeated for a maximum of 6 credit hours.

PYPS 7990 RESEARCH AND THESIS (1-10) MST. Research for Masters students. Course may be repeated with change in topics.

PYPS 8930 DIRECTED STUDIES IN PHARMACAL SCIENCES (1-3) LEC. Departmental approval. Selected laboratory research topics in the pharmaceutical sciences. Course may be repeated for a maximum of 6 credit hours.

PYPS 8950 SEMINAR (1) SEM. 1. SU. 1 CR; may be repeated multiple times for credit. Course may be repeated for a maximum of 10 credit hours.

PYPS 8960 DIRECTED READINGS IN PHARMACAL SCIENCES (1-3) IND. Pr. At least 6 credits each with a minimum grade of B in PYPS 7000-7999 Selected study topics in the pharmaceutical sciences. 09 PYSC standing or departmental approval and 6 hours of 7000-level courses. Course may be repeated for a maximum of 6 credit hours.

PYPS 8990 RESEARCH AND DISSERTATION (1-10) DSR. Research for doctoral students. Course may be repeated with change in topics.

Pharmacy Care Systems Courses

PYPC 7510 HEALTH SERVICES DELIVERY AND EVALUATION (3) LEC. 3. Enrollment in the MS or PhD Program in Pharmaceutical Science with Health Outcomes Research and Policy Option or Departmental approval. Introduction to basic methods and frameworks for undertaking research and program evaluation within health services organizations and systems.

PYPC 7520 SOCIAL AND BEHAVIORAL THEORY IN HEALTH (3) LEC. 3. Enrollment in the MS or PhD Program in Pharmaceutical Science with Health Outcomes Research and Policy Option or Departmental approval. Introduction to the basic theories of behavior and intervention used in practice and research to evaluate changes in health, humanistic, and economic outcomes among patients.

PYPC 7530 PHARMACEUTICAL ECONOMICS, OUTCOMES, AND POLICY (3) LEC. 3. Enrollment in the MS or PhD Program in Pharmaceutical Science with Health Outcomes Research and Policy Option or Departmental approval. The graduate-level course is intended to introduce students to concepts relevant to pharmaceutical outcomes, economics, and policy. The course provides foundational knowledge surrounding healthcare.

PYPC 7540 PHARMACOEPIDEMIOLOGY: METHODS AND APPLICATIONS (3) LEC. 3. Enrollment in the MS or PhD Program in Pharmaceutical Science with Health Outcomes Research and Policy Option or Departmental approval. STAT 6110 or equivalent SAS training. The course covers topics in pharmacoepidemiology focusing on the methods and applications of analyzing large healthcare claims databases and electronic medical records.

PYPC 7720 MOTIVATIONAL INTERVIEWING FOR HEALTH BEHAVIORS (3) LEC. 2, IND/LEC. 1. Enrollment in the MS or PhD Program in Pharmaceutical Science with Health Outcomes Research and Policy Option or Departmental approval. Concepts, current research applications, and intervention development training in motivational interviewing for health behavior change interventions.

PYPC 7810 HOSPITAL PHARMACY ADMINISTRATION (2) LEC. 2. Administrative and policy-making procedures. Provides understanding of socioeconomic aspects of hospital pharmacy practice and competence in selected administrative skills.

PYPC 7820 RESEARCH METHODS AND DESIGN HEALTH SCIENCE I (2) LEC. 2. Departmental approval. Application of scientific methods in health care.

PYPC 7830 RESEARCH METHODS IN THE HEALTH SCIENCES II (3) LEC. 3. Pr. PYPC 7820. Application of the principles and concepts obtained in PYPC 7820.

PYPC 7840 MEDICATION INFORMATION SYSTEMS (3) LEC. 3. Health system informatics theories and methodologies. Demonstration of how information reduces uncertainty in health-care decision-making.

PYPC 7860 THE PHARMACIST'S ROLE IN IMPROVING PATIENT ADHERENCE (3) LEC. 3. Pr. PYPC 7820. Theories and methodologies involved in adherence to medication regimens.

PYPC 7870 SOCIAL, BEHAVIORAL, AND ADMINISTRATIVE ASPECTS OF PHARMACY PRACTICE (3) LEC. 3. Theories and applications in social, behavioral, and administrative aspects of pharmacy practice and medication use systems.

PYPC 7950 SEMINAR (1) SEM. 1. SU. 1 CR; may be repeated multiple times for credit. Required of all Pharmaceutical Science MS students with Health Outcomes Research and Policy Option. Course may be repeated for a maximum of 6 credit hours.

PYPC 7960 SPECIAL PROBLEMS IN PHARMACY CARE SYSTEMS (2-3) LEC. Departmental approval. Special problems. Course may be repeated for a maximum of 6 credit hours.

PYPC 7990 RESEARCH AND THESIS (1-10) MST. Credit hours to be arranged. Course may be repeated with a change in topic. Course may be repeated with change in topics.

PYPC 8950 SEMINAR (1) SEM. 1. SU. 1 CR; may be repeated multiple times for credit. Required of all Pharmaceutical Science PhD students with Health Outcomes Research and Policy Option. Course may be repeated for a maximum of 10 credit hours.

PYPC 8960 SPECIAL PROBLEMS IN PHARMACY CARE SYSTEMS (1-3) LEC. Departmental approval. Credit hours to be arranged. Course may be repeated for a maximum of 6 credit hours.

PYPC 8990 RESEARCH AND DISSERTATION (1-10) DSR. Credit hours to be arranged. Course may be repeated with change in topics.

Health Outcomes Res & Policy

  • FOX, BRENT I., Associate Professor
  • GARZA, KIMBERLY BOSWORTH, Assistant Professor
  • HANSEN, RICHARD A., Professor and Head
  • KAVOOKJIAN, JAN, Associate Professor
  • McgINN, KAITLIN, Assistant Clinical Professor
  • QIAN, JINGJING, Assistant Professor
  • SCALESE, MICHAEL J., Assistant Clinical Professor
  • WESTRICK, SALISA C., Associate Professor

Pharmacy Practice

  • ANDRUS, MIRANDA R., Associate Clinical Professor
  • ARMSTRONG, EMILY M., Assistant Clinical Professor
  • BRAXTON-LLOYD, KIMBERLY, Associate Professor
  • BULLOCK, MARILYN J., Assistant Clinical Professor
  • CARROLL, DANA G., Associate Clinical Professor
  • CHUNG, ALLISON M., Associate Clinical Professor
  • DURHAM, SPENCER HOLAWAY, Assistant Clinical Professor
  • EILAND, LEA C., Clinical Professor
  • EVANS, R. LEE, Professor and Dean
  • HELMER, ROBERT S., Assistant Clinical Professor
  • HELMS, KRISTEN, Associate Clinical Professor
  • HESTER, E. KELLY, Associate Clinical Professor
  • HORNSBY, LORI B., Associate Clinical Professor
  • HUTCHISON, AMBER M., Assistant Clinical Professor
  • JACKSON, CHERRY W., Professor
  • JUNGNICKEL, PAUL W., Professor and Associate Dean
  • KELLEY, KRISTI W., Associate Clinical Professor
  • KLEPPINGER, ERIKA L., Associate Clinical Professor
  • LEE, PHILIP H., Assistant Clinical Professor
  • LINDSEY, WESLEY T., Associate Clinical Professor
  • LISENBY, KATELIN M, Assistant Clinical Professor
  • MARLOWE, KAREN F., Associate Professor and Assistant Dean
  • OLIN, BERNIE R. III, Associate Clinical Professor
  • PHILLIPPE, HALEY M., Associate Clinical Professor
  • PINNER, NATHAN A., Assistant Clinical Professor
  • SACKS, GORDON S., Professor and Head
  • SLATER, NICOLE A., Assistant Clinical Professor
  • STAMM, PAMELA L., Associate Professor
  • STARR, JESSICA A., Associate Clinical Professor
  • THOMAS, SELBY G., Assistant Professor
  • WHITELY, HEATHER P., Associate Clinical Professor
  • WILLIAMSON, MARGARET A., Assistant Clinical Professor
  • WRIGHT, BRAD, Associate Clinical Professor

Drug Discovery and Development

  • AMIN, RAJESH H., Assistant Professor
  • ARNOLD, ROBERT D., Associate Professor
  • CALDERON, ANGELA I., Associate Professor
  • CLARK, C. RANDALL, Professor
  • DERUITER, JACK, Professor
  • DHANASEKARAN, MURALIKRISHNAN, Associate Professor
  • MEYER, ALLISON, Assistant Clinical Professor
  • PANIZZI, PETER R., Assistant Professor
  • RAMAPURAM, JAYACHANDRA, Associate Professor
  • RIESE, DAVID J. II, Professor and Associate Dean
  • SHEN, JIANZHONG, Associate Professor
  • SMITH, FORREST T., Associate Professor
  • SUPPIRAMANIAM, VISHNU, Associate Professor and Interim Head